Zuqing Nie - Publications

Case Report: Clinicopathological features of bladder neuroendocrine neoplasm: a retrospective case series of nine cases and literature review.

Journal: Frontiers in oncology

Published: April 10, 2026

Nanomaterial-Enhanced Immunotherapy: Advancing T-Cell-Based Treatments for Bladder Cancer.

Journal: International journal of nanomedicine

Published: August 03, 2025

From fat to tumor: Exploring the inflammatory bridge via CRP in obesity-related bladder cancer.

Journal: Medicine

Published: May 26, 2025

Treg Cells Modulate Neuroinflammation and Behavioral Deficits in Autism: Evidence From MR-Based Genetic Analyses and Experimental Models.

Journal: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Published: February 16, 2025

Blood metabolites as mediators in erectile dysfunction: insights from a multi-center proteomics and genetic study.

Journal: Frontiers in pharmacology

Published: January 30, 2025

Engineering HSV-1 for oncolytic therapy: From molecular entry mechanisms to retargeting strategies.

Journal: Genes & diseases

Published: December 06, 2024

Observed improvements in immune parameters and behavioral symptoms following low-dose IL-2 treatment in four autistic children with immune dysfunction.

Journal: BMC psychiatry

Published: July 07, 2024

LdIL-2 treatment in ASD: a novel immunotherapeutic approach targeting Th/Treg dysfunction and neuroinflammation.

Journal: Translational psychiatry

Published: April 02, 2024

Comparative evaluation of immunomodulatory cytokines for oncolytic therapy based on a high-efficient platform for oHSV1 reconstruction.

Journal: Virology journal

Published: March 20, 2024

Dysbiotic Gut Microbiota and Dysregulation of Cytokine Profile in Children and Teens With Autism Spectrum Disorder.

Journal: Frontiers in neuroscience

Published: November 30, 2020

Construction and Optimization of Herpes Simplex Virus Vectors for Central Nervous System Gene Delivery based on CRISPR/Cas9-mediated Genome Editing.

Journal: Current gene therapy

Published: November 17, 2020